Immunohistochemical analysis of SOX2 expression in small‑cell neuroendocrine carcinoma of the endometrium

Ebisu,Yusuke; Ishida,Mitsuaki; Mizokami,Tomomi; Kita,Masato; Okada,Hidetaka; Tsuta,Koji

doi:10.3892/mco.2020.2051

Immunohistochemical analysis of SOX2 expression in small‑cell neuroendocrine carcinoma of the endometrium

Authors:
- Yusuke Ebisu
- Mitsuaki Ishida
- Tomomi Mizokami
- Masato Kita
- Hidetaka Okada
- Koji Tsuta
View Affiliations

Affiliations: Department of Pathology and Laboratory Medicine, Kansai Medical University, Hirakata, Osaka 573‑1010, Japan, Department of Obstetrics and Gynaecology, Kansai Medical University, Hirakata, Osaka 573‑1010, Japan
Published online on: May 22, 2020 https://doi.org/10.3892/mco.2020.2051
Pages: 115-118
Copyright: © Ebisu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Small‑cell neuroendocrine carcinoma (NEC) of the endometrium is an extremely rare and highly aggressive carcinoma. Sex‑determining region Y‑box 2 (SOX2) is a master transcription factor regulating the self‑renewal, maintenance of stem cell properties and pluripotency of embryonic stem cells, and recent studies revealed that SOX2 plays important roles in cancer growth and progression in several types of carcinomas, including small‑cell neuroendocrine carcinoma (NEC) of the lung and oesophagus. Few studies to date have analysed the association between SOX2 and endometrioid carcinoma, whereas the expression of SOX2 in small‑cell NEC of the endometrium has not been investigated. The aim of the present study was to analyse the expression status of SOX2, p16 and paired‑box gene (PAX) 8, a useful Müllerian marker, in endometrial small‑cell NEC. A total of 4 patients with small‑cell NEC of the endometrium were enrolled (median age, 70 years). Immunohistochemical studies revealed SOX2 expression in 3 patients and p16 expression in all patients. No patients exhibited positive immunoreactivity for PAX8. SOX2 expression has been reported to be associated with the pathogenesis of small‑cell NEC of the oesophagus. Therefore, the results of the present study indicated that SOX2 expression plays an important role in the development of small‑cell NEC of the endometrium and the oesophagus. Moreover, expression of p16 and loss of PAX8 do not indicate the origin of small‑cell NEC of the endometrium.

View Figures

View References

1	Zaio R, Carinelli SG, Ellenson LH, Eng C, Katabuchi H, Konishi I, Lax S, Matias-Guiu X, Mutter GL, Peters WA III, et al: Epithelial tumours and precursors. In: Kurman RJ Carcangiu ML Herrington S and Young RH (eds). WHO classification of tumours of female reproductive organs. 4th edition. Lyon, IARC. pp125–135. 2014.
2	Pocrnich CE, Ramalingam P, Euscher ED and Malpica A: Neuroendocrine carcinoma of the endometrium: A clinicopathologic study of 25 cases. Am J Surg Pathol. 40:577–586. 2016.PubMed/NCBI View Article : Google Scholar
3	Ishida M, Iwamoto N, Nakagawa T, Kaku S, Iwai M, Kagotani A, Takahashi K, Murakami T and Okabe H: Small cell carcinoma of the endometrium: A case report with emphasis on the cytological features. Int J Clin Exp Pathol. 7:3332–3337. 2014.PubMed/NCBI
4	Adachi K, Nikaido I, Ohta H, Ohtsuka S, Ura H, Kadota M, Wakayama T, Ueda HR and Niwa H: Context-dependent wiring of Sox2 regulatory networks for self-renewal of embryonic and trophoblast stem cells. Mol Cell. 52:380–392. 2013.PubMed/NCBI View Article : Google Scholar
5	Sholl LM, Long KB and Hornick JL: Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol. 18:55–61. 2010.PubMed/NCBI View Article : Google Scholar
6	Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T and Takemasa I: SOX2 and ALDH1 as predictors of operable breast cancer. Anticancer Res. 36:2945–2953. 2016.PubMed/NCBI
7	Basati G, Mohammadpour H and Emami Razavi A: Association of high expression levels of SOX2, NANOG, and OCT4 in gastric cancer tumor tissues with progression and poor prognosis. J Gastrointest Cancer. 51:41–47. 2020.PubMed/NCBI View Article : Google Scholar
8	Herreros-Villanueva M, Bujanda L, Billadeau DD and Zhang JS: Embryonic stem cell factors and pancreatic cancer. World J Gastroenterol. 20:2247–2254. 2014.PubMed/NCBI View Article : Google Scholar
9	Santini R, Pietrobono S, Pandolfi S, Montagnani V, D'Amico M, Penachioni JY, Vinci MC, Borgognoni L and Stecca B: SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene. 33:4697–4708. 2014.PubMed/NCBI View Article : Google Scholar
10	Yamawaki K, Ishiguro T, Mori Y, Yoshihara K, Suda K, Tamura R, Yamaguchi M, Sekine M, Kashima K, Higuchi M, et al: Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer. Cancer Sci. 108:632–640. 2017.PubMed/NCBI View Article : Google Scholar
11	Lee CJ, Sung PL, Kuo MH, Tsai MH, Wang CK, Pan ST, Chen YJ, Wang PH, Wen KC and Chou YT: Crosstalk between SOX2 and cytokine signaling in endometrial carcinoma. Sci Rep. 8(17550)2018.PubMed/NCBI View Article : Google Scholar
12	Pityński K, Banas T, Pietrus M, Milian-Ciesielska K, Ludwin A and Okon K: SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading. Int J Clin Exp Pathol. 8:8189–8198. 2015.PubMed/NCBI
13	Ishida H, Kasajima A, Kamei T, Miura T, Oka N, Yazdani S, Ozawa Y, Fujishima F, Sakurada A, Nakamura Y, et al: SOX2 and Rb1 in esophageal small-cell carcinoma: Their possible involvement in pathogenesis. Mod Pathol. 30:660–671. 2017.PubMed/NCBI View Article : Google Scholar
14	Ebisu Y, Ishida M, Okano K, Sandoh K, Mizokami T, Kita M, Okada H and Tsuta K: Small-cell neuroendocrine carcinoma in directly sampled endometrial cytology: A monocentric retrospective study of six cases. Diagn Cytopathol. 47:1297–1301. 2019.PubMed/NCBI View Article : Google Scholar
15	Masai K, Tsuta K, Kawago M, Tatsumori T, Kinno T, Taniyama T, Yoshida A, Asamura H and Tsuda H: Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol. 21:292–297. 2013.PubMed/NCBI View Article : Google Scholar
16	Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS and Ronnett BM: Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: Immunohistochemical analysis of 201 cases. Am J Surg Pathol. 33:1504–1514. 2009.PubMed/NCBI View Article : Google Scholar
17	McCluggage WG, Kennedy K and Busam KJ: An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol. 34:525–532. 2010.PubMed/NCBI View Article : Google Scholar
18	Ordóñez NG: Value of PAX 8 immunostaining in tumor diagnosis: A review and update. Adv Anat Pathol. 19:140–151. 2012.PubMed/NCBI View Article : Google Scholar